Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy

18Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Over the last decades, the global life expectancy of the population has increased, and so, consequently, has the risk of cancer development. Despite the improvement in cancer therapies (e.g., drug delivery systems (DDS) and theranostics), in many cases recurrence continues to be a challenging issue. In this matter, the development of nanotechnology has led to an array of possibilities for cancer treatment. One of the most promising therapies focuses on the assembly of hierarchical structures in the form of nanoclusters, as this approach involves preparing individual building blocks while avoiding handling toxic chemicals in the presence of biomolecules. This review aims at presenting an overview of the major advances made in developing nanoclusters based on polymeric nanoparticles (PNPs) and/or inorganic NPs. The preparation methods and the features of the NPs used in the construction of the nanoclusters were described. Afterwards, the design, fabrication and properties of the two main classes of nanoclusters, namely noble-metal nanoclusters and hybrid (i.e., hetero) nanoclusters and their mode of action in cancer therapy, were summarized.

Cite

CITATION STYLE

APA

Zumaya, A. L. V., Mincheva, R., Raquez, J. M., & Hassouna, F. (2022, March 1). Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy. Polymers. MDPI. https://doi.org/10.3390/polym14061188

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free